Company Overview
About ChromaCode
ChromaCode is a molecular diagnostics company developing High-Definition PCR (HDPCR), a breakthrough multiplexing platform that dramatically expands the number of analytes detectable in a single PCR well using standard laboratory instruments. By combining proprietary chemistry with amplitude modulation, multi-spectral encoding, and cloud-based decoding software, HDPCR enables labs to run panels for infectious disease, oncology biomarkers, transplant monitoring, and prenatal testing without expensive new hardware.
Business Model & Competitive Advantage
The company''s ChromaCode Cloud software automates signal decoding and delivers comprehensive results in minutes. ChromaCode has received FDA Emergency Use Authorization for COVID-19 testing and has commercially launched assays for tick-borne pathogens. Strategic investment from oncology-focused partners has advanced HDPCR applications into non-small-cell lung cancer and other solid tumor indications.
Competitive Landscape 2025–2026
ChromaCode is partnering with MedGenome to expand HDPCR-based diagnostics into India and the Middle East, broadening access to affordable, high-throughput molecular testing in underserved markets.
Key Differentiators
Strong Challenger
ChromaCode is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare ChromaCode with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from ChromaCode? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim ChromaCode Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention ChromaCode vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →